<code id='C4400F7F86'></code><style id='C4400F7F86'></style>
    • <acronym id='C4400F7F86'></acronym>
      <center id='C4400F7F86'><center id='C4400F7F86'><tfoot id='C4400F7F86'></tfoot></center><abbr id='C4400F7F86'><dir id='C4400F7F86'><tfoot id='C4400F7F86'></tfoot><noframes id='C4400F7F86'>

    • <optgroup id='C4400F7F86'><strike id='C4400F7F86'><sup id='C4400F7F86'></sup></strike><code id='C4400F7F86'></code></optgroup>
        1. <b id='C4400F7F86'><label id='C4400F7F86'><select id='C4400F7F86'><dt id='C4400F7F86'><span id='C4400F7F86'></span></dt></select></label></b><u id='C4400F7F86'></u>
          <i id='C4400F7F86'><strike id='C4400F7F86'><tt id='C4400F7F86'><pre id='C4400F7F86'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:8
          New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

          CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

          Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Neutralizing antibodies against HIV shows promise in children
          Neutralizing antibodies against HIV shows promise in children

          BuddingHIVvirions.NIAID/NIHWhenchildrenlivingwithHIVareinjectedwithneutralizingantibodies,thetreatme

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Ahead of JPM, here's who's profiting most in health care

          AdobeForalltheflaktheyget,thecountry’sfourbiggestpharmacybenefitmanagersreportedasurprisinglytameave